A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease - Rogers, SL; Farlow, MR; Doody, RS; Mohs, R; Friedhoff, LT; and the Donepezil Study Group (Neurology, 1998)